Cite
HARVARD Citation
Verma, A. et al. (2021). From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative. Lancet gastroenterology and hepatology. pp. 88-89. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Verma, A. et al. (2021). From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative. Lancet gastroenterology and hepatology. pp. 88-89. [Online].